CYH - Community Health Systems, Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Franklin,
United States
Type: Equity
CYH price evolution
CYH
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $48 | $38 | $91 | $118 |
| Short term investments | ||||
| Net receivables | $2194 | $2231 | $2160 | $2043 |
| Inventory | $329 | $328 | $325 | $333 |
| Total current assets | $3175 | $3208 | $3248 | $3192 |
| Long term investments | ||||
| Property, plant & equipment | $5219 | $5207 | $5160 | $5250 |
| Goodwill & intangible assets | $3957 | $3958 | $3943 | $4054 |
| Total noncurrent assets | $11242 | $11247 | $11426 | $11456 |
| Total investments | ||||
| Total assets | $14417 | $14455 | $14674 | $14648 |
| Current liabilities | ||||
| Accounts payable | $941 | $912 | $837 | $736 |
| Deferred revenue | ||||
| Short long term debt | $149 | $145 | $143 | $164 |
| Total current liabilities | $2136 | $2142 | $2149 | $2076 |
| Long term debt | $12079 | $12029 | $12380 | $12308 |
| Total noncurrent liabilities | $13159 | $13137 | $13418 | $13392 |
| Total debt | $12228 | $12174 | $12523 | $12472 |
| Total liabilities | $15295 | $15279 | $15567 | $15468 |
| Shareholders' equity | ||||
| Retained earnings | -$3605 | -$3564 | -$3611 | -$3520 |
| Other shareholder equity | -$16 | -$14 | -$23 | -$19 |
| Total shareholder equity | -$1428 | -$1392 | -$1463 | -$1489 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $38 | $118 | $507 | $1676 |
| Short term investments | ||||
| Net receivables | $2231 | $2137 | $2062 | $1927 |
| Inventory | $328 | $353 | $355 | $335 |
| Total current assets | $3208 | $3082 | $3479 | $4510 |
| Long term investments | $190 | |||
| Property, plant & equipment | $5207 | $6103 | $5553 | $5322 |
| Goodwill & intangible assets | $3958 | $4166 | $4219 | $4219 |
| Total noncurrent assets | $11247 | $11587 | $11738 | $11496 |
| Total investments | ||||
| Total assets | $14455 | $14669 | $15217 | $16006 |
| Current liabilities | ||||
| Accounts payable | $912 | $773 | $830 | $783 |
| Deferred revenue | ||||
| Short long term debt | $145 | $169 | $178 | $265 |
| Total current liabilities | $2142 | $2186 | $2364 | $2815 |
| Long term debt | $12029 | $11614 | $12644 | $12617 |
| Total noncurrent liabilities | $13137 | $13217 | $13663 | $14245 |
| Total debt | $12174 | $12388 | $12822 | $12882 |
| Total liabilities | $15279 | $16036 | $16027 | $17060 |
| Shareholders' equity | ||||
| Retained earnings | -$3564 | -$3431 | -$3477 | -$3707 |
| Other shareholder equity | -$14 | -$2 | -$14 | -$13 |
| Total shareholder equity | -$1392 | -$1367 | -$1372 | -$1625 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3140 | $3182 | $3086 | $3115 |
| Cost of revenue | $487 | $494 | $489 | $504 |
| Gross Profit | $2653 | $2688 | $2597 | $2611 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2213 | $2239 | $2191 | $2174 |
| Total operating expenses | $2405 | $2439 | $2398 | $2378 |
| Operating income | $248 | $249 | $199 | $233 |
| Income from continuing operations | ||||
| EBIT | $198 | $363 | $136 | $207 |
| Income tax expense | $28 | $107 | $19 | $38 |
| Interest expense | $211 | $209 | $208 | $207 |
| Net income | ||||
| Net income | -$41 | $47 | -$91 | -$38 |
| Income (for common shares) | -$41 | $47 | -$91 | -$38 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12490 | $12211 | $12368 | $11789 |
| Cost of revenue | $1993 | $1975 | $2042 | $1963 |
| Gross Profit | $10497 | $10236 | $10326 | $9826 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $8803 | $8666 | $8200 | $8368 |
| Total operating expenses | $9627 | $9344 | $8900 | $8652 |
| Operating income | $870 | $892 | $1426 | $1174 |
| Income from continuing operations | ||||
| EBIT | $888 | $1074 | $1246 | $1357 |
| Income tax expense | $191 | $170 | $131 | -$185 |
| Interest expense | $830 | $858 | $885 | $1031 |
| Net income | ||||
| Net income | -$133 | $46 | $230 | $511 |
| Income (for common shares) | -$133 | $46 | $230 | $511 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$41 | $47 | -$91 | -$38 |
| Operating activities | ||||
| Depreciation | $115 | $121 | $129 | $123 |
| Business acquisitions & disposals | -$5 | $303 | -$9 | $10 |
| Stock-based compensation | $6 | $6 | $6 | $4 |
| Total cash flows from operations | $96 | $90 | $29 | $86 |
| Investing activities | ||||
| Capital expenditures | -$92 | -$109 | -$127 | -$86 |
| Investments | -$2 | -$14 | $35 | -$10 |
| Total cash flows from investing | -$99 | $180 | -$101 | -$86 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$2 | |||
| Net borrowings | $65 | -$291 | $69 | $12 |
| Total cash flows from financing | $13 | -$323 | $45 | -$26 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $10 | -$53 | -$27 | -$26 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$133 | $46 | $230 | $511 |
| Operating activities | ||||
| Depreciation | $505 | $534 | $540 | $558 |
| Business acquisitions & disposals | $383 | $182 | $117 | $647 |
| Stock-based compensation | $22 | $20 | $25 | $13 |
| Total cash flows from operations | $210 | $300 | -$131 | $2178 |
| Investing activities | ||||
| Capital expenditures | -$439 | -$377 | -$459 | -$436 |
| Investments | $30 | -$64 | -$182 | -$34 |
| Total cash flows from investing | -$26 | -$259 | -$524 | $177 |
| Financing activities | ||||
| Dividends paid | -$116 | |||
| Sale and purchase of stock | -$4 | -$8 | -$5 | -$1 |
| Net borrowings | -$123 | -$305 | -$369 | -$794 |
| Total cash flows from financing | -$264 | -$430 | -$514 | -$895 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$80 | -$389 | -$1169 | $1460 |
News
Fundamentals
| Market cap | $448.86M |
|---|---|
| Enterprise value | $12.63B |
| Shares outstanding | 138.97M |
| Revenue | $12.52B |
|---|---|
| EBITDA | $1.39B |
| EBIT | $904.00M |
| Net Income | -$123.00M |
| Revenue Q/Q | 1.03% |
| Revenue Y/Y | 2.57% |
| P/E ratio | -3.65 |
|---|---|
| EV/Sales | 1.01 |
| EV/EBITDA | 9.07 |
| EV/EBIT | 13.97 |
| P/S ratio | 0.04 |
| P/B ratio | -0.32 |
| Book/Share | -10.16 |
| Cash/Share | 0.35 |
| EPS | -$0.89 |
|---|---|
| ROA | -0.85% |
| ROE | 8.52% |
| Debt/Equity | -10.98 |
|---|---|
| Net debt/EBITDA | 10.95 |
| Current ratio | 1.49 |
| Quick ratio | 1.33 |